BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37068594)

  • 21. Could venous thromboembolism and major bleeding be indicators of lung cancer mortality? A nationwide database study.
    Howlett J; Benzenine E; Cottenet J; Foucher P; Fagnoni P; Quantin C
    BMC Cancer; 2020 May; 20(1):461. PubMed ID: 32448219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duration of anticoagulant therapy and VTE recurrence in patients with cancer.
    Khorana AA; McCrae KR; Milentijevic D; Fortier J; Nelson WW; Laliberté F; Crivera C; Lefebvre P; Schein J
    Support Care Cancer; 2019 Oct; 27(10):3833-3840. PubMed ID: 30734088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study.
    Chee CE; Ashrani AA; Marks RS; Petterson TM; Bailey KR; Melton LJ; Heit JA
    Blood; 2014 Jun; 123(25):3972-8. PubMed ID: 24782507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism.
    Lecumberri R; Alfonso A; Jiménez D; Fernández Capitán C; Prandoni P; Wells PS; Vidal G; Barillari G; Monreal M;
    Thromb Haemost; 2013 Oct; 110(4):834-43. PubMed ID: 23846721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
    Marik PE; Cavallazzi R
    PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue Factor As a Predictor of Recurrent Venous Thromboembolism in Malignancy: Biomarker Analyses of the CATCH Trial.
    Khorana AA; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Lee AY
    J Clin Oncol; 2017 Apr; 35(10):1078-1085. PubMed ID: 28029329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occult cancer-related first venous thromboembolism is associated with an increased risk of recurrent venous thromboembolism.
    Gran OV; Braekkan SK; Paulsen B; Skille H; Rosendaal FR; Hansen JB
    J Thromb Haemost; 2017 Jul; 15(7):1361-1367. PubMed ID: 28440069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk.
    Muriel A; Jiménez D; Aujesky D; Bertoletti L; Decousus H; Laporte S; Mismetti P; Muñoz FJ; Yusen R; Monreal M;
    J Am Coll Cardiol; 2014 Apr; 63(16):1675-83. PubMed ID: 24576432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison Between Non-vitamin K Antagonist Oral Anticoagulants and Low-Molecular-Weight Heparin in Asian Individuals With Cancer-Associated Venous Thromboembolism.
    Chen DY; Tseng CN; Hsieh MJ; Lan WC; Chuang CK; Pang ST; Chen SW; Chen TH; Chang SH; Hsieh IC; Chu PH; Wen MS; Chen JS; Chang JW; See LC; Huang WK
    JAMA Netw Open; 2021 Feb; 4(2):e2036304. PubMed ID: 33533929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer-associated venous thromboembolism in the direct oral anticoagulants era: Insight from the COMMAND VTE Registry-2.
    Chatani R; Yamashita Y; Morimoto T; Mushiake K; Kadota K; Kaneda K; Nishimoto Y; Ikeda N; Kobayashi Y; Ikeda S; Kim K; Inoko M; Takase T; Tsuji S; Oi M; Takada T; Otsui K; Sakamoto J; Ogihara Y; Inoue T; Usami S; Chen PM; Togi K; Koitabashi N; Hiramori S; Doi K; Mabuchi H; Tsuyuki Y; Murata K; Takabayashi K; Nakai H; Sueta D; Shioyama W; Dohke T; Nishikawa R; Kimura T;
    Thromb Res; 2024 Feb; 234():86-93. PubMed ID: 38190788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study.
    Campello E; Spiezia L; Simion C; Tormene D; Camporese G; Dalla Valle F; Poretto A; Bulato C; Gavasso S; Radu CM; Simioni P
    J Am Heart Assoc; 2020 Dec; 9(23):e018917. PubMed ID: 33222589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of the Ottawa Score to Predict the Risk of Recurrent Venous Thromboembolism in Cancer Patients: The Prospective PREDICARE Cohort Study.
    Girard P; Laporte S; Chapelle C; Falvo N; Falchero L; Cloarec N; Monnet I; Burnod A; Tomasini P; Boulon C; Debourdeau P; Boutruche B; Scotté F; Lamblin A; Meyer G
    Thromb Haemost; 2022 Jan; 122(1):151-157. PubMed ID: 33878800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do Patients with a Family or Personal History of Venous Thromboembolism have an Increased Risk of Recurrence?
    Florin J; Stalder O; Baumgartner C; Méan M; Rodondi N; Aujesky D
    Thromb Haemost; 2022 Jun; 122(6):1017-1026. PubMed ID: 34963186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High rate of recurrent venous thromboembolism in children and adolescents with unprovoked venous thromboembolism.
    Whitworth H; Clark HH; Hubbard RA; Witmer C; Leonard CE; Raffini L
    J Thromb Haemost; 2023 Jan; 21(1):47-56. PubMed ID: 36695395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use.
    Blanco-Molina Á; Trujillo-Santos J; Pesavento R; Rosa V; Falgá C; Tolosa C; Mazzolai L; Sampériz Á; Duce R; Monreal M;
    Thromb Res; 2017 Mar; 151 Suppl 1():S6-S10. PubMed ID: 28262237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study.
    Le Moigne E; Delluc A; Tromeur C; Nowak E; Mottier D; Lacut K; Le Gal G
    Thromb Res; 2013 Jul; 132(1):51-5. PubMed ID: 23786893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of Recurrent Venous Thromboembolism or Arterial Thrombotic Events during and after Anticoagulation for a First Venous Thromboembolism.
    Noumegni SR; Tromeur C; Hoffmann C; Mao RL; Moigne EL; Moreuil C; Mansourati V; Nasr B; Gentric JC; Guegan M; Poulhazan E; Bressollette L; Lacut K; Didier R; Couturaud F
    Semin Thromb Hemost; 2023 Oct; 49(7):688-701. PubMed ID: 36252603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of recurrent venous thromboembolism and bleeding on anticoagulation.
    Menapace LA; McCrae KR; Khorana AA
    Thromb Res; 2016 Apr; 140 Suppl 1():S93-8. PubMed ID: 27067987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hospital-related first venous thromboembolism and risk of recurrence.
    Bjøri E; Arshad N; Johnsen HS; Hansen JB; Braekkan SK
    J Thromb Haemost; 2016 Dec; 14(12):2368-2375. PubMed ID: 27589573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.